Source link : https://www.newshealth.biz/health-news/btk-inhibitor-active-in-half-of-patients-with-richter-transformation/
Half of patients with Richter transformation responded to the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib (Jaypirca), and most had received prior BTK treatment, a multicenter study showed. Complete responses occurred in 11 of 82 patients (13%), and 30 patients (37%) had partial responses. Almost half of the responses lasted 12 months or longer. Eight patients […]
Author : News Health
Publish date : 2024-09-03 20:31:26
Copyright for syndicated content belongs to the linked Source.